Castle Biosciences (CSTL) Interest & Investment Income (2018 - 2026)

Castle Biosciences has disclosed Interest & Investment Income across 9 years of filings, most recently posting $2.5 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $2.5 million, down 17.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (down 13.83% YoY), and the FY2025 annual result was $11.8 million, down 8.86% from the prior year.
• Interest & Investment Income came in at $2.5 million for Q1 2026 at Castle Biosciences, down from $2.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.4 million in Q3 2024 to a low of $30000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $2.8 million (2025), against an average of $2.5 million.
• Across the five-year window, Interest & Investment Income jumped 13282.35% in 2022 and dropped 17.88% in 2026, its largest moves.
• Castle Biosciences' Interest & Investment Income stood at $2.3 million in 2022, then soared by 37.1% to $3.1 million in 2023, then rose by 8.11% to $3.4 million in 2024, then declined by 14.12% to $2.9 million in 2025, then fell by 12.12% to $2.5 million in 2026.
• The last three Interest & Investment Income figures came in at $2.5 million (Q1 2026), $2.9 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.